Skip to content
Home/Companies/Biotech/Ermium Therapeutics

Ermium Therapeutics

Biotech·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Ermium Therapeutics?

Ermium Therapeutics is a French Biotech company, currently owned by Erganeo since 2019.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Erganeo
Investor
Erganeo
Erganeo · 2012 · VC

Key facts

HQFrance
SectorBiotech

More from Erganeo

Other portfolio companies in the same fund.

Greennovation
Active
France· 2025
Lafame
Active
France· 2025
PegmaTiss BioTech
Active
HealthcareFrance· 2023
Izonics
Active
IndustrialsFrance· 2022
Persea
Active
BiotechFrance· 2022
AbilyCare
Active
HealthTechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Ermium Therapeutics?

Ermium Therapeutics is currently owned by Erganeo, through Erganeo, since 2019.

When did Erganeo acquire Ermium Therapeutics?

Erganeo acquired Ermium Therapeutics in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue